Legislative, Regulatory & Legal

Alimera’s lawsuit asks the court to require ANI to comply with its obligations to complete the transaction as contemplated by the merger agreement.

NCPA is urging CMS to eliminate abuses by plans and PBMs in Part D and ensure patient access to accurate information.

Savings from biosimilar medicines alone increased to $12.4 billion in 2023 and $36 billion since the first biosimilar entry in 2015, according to AAM's latest report.

Rite Aid named Matt Schroeder its new CEO the same day the company emerged from Chapter 11 bankruptcy protection.

NCPA Annual Convention will run from Oct. 26 to 29.

Discussions centered around the soaring DIR Fees and the dominance of major PBMs in the market.

The U.S. Federal Trade Commission’s lawsuit to block Kroger-Albertson’s merger went to trial today in federal court in Portland, Ore.

The Guidance would support biologic drug competition, increase patient access to biosimilars and lower healthcare costs for patients, the FTC’s comment says.